Incyte
INCY
#1110
Rank
ยฃ15.10 B
Marketcap
ยฃ76.96
Share price
2.05%
Change (1 day)
31.06%
Change (1 year)

Incyte (INCY) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ2.19 Billion

According to Incyte's latest financial reports the company has ยฃ2.19 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Incyte - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ1.71 B-40.07%
2023-12-31ยฃ2.86 B7.19%
2022-12-31ยฃ2.67 B53.9%
2021-12-31ยฃ1.73 B31.63%
2020-12-31ยฃ1.32 B-18.16%
2019-12-31ยฃ1.61 B42.51%
2018-12-31ยฃ1.13 B30.93%
2017-12-31ยฃ0.86 B32.07%
2016-12-31ยฃ0.65 B37.2%
2015-12-31ยฃ0.47 B23.88%
2014-12-31ยฃ0.38 B24.94%
2013-12-31ยฃ0.30 B118.35%
2012-12-31ยฃ0.14 B-20.87%
2011-12-31ยฃ0.17 B-35%
2010-12-31ยฃ0.27 B-5.48%
2009-12-31ยฃ0.29 B115.16%
2008-12-31ยฃ0.13 B4.68%
2007-12-31ยฃ0.12 B-20.64%
2006-12-31ยฃ0.16 B-18.7%
2005-12-31ยฃ0.20 B-18.25%
2004-12-31ยฃ0.24 B48.98%
2003-12-31ยฃ0.16 B-38.61%
2002-12-31ยฃ0.26 B-23.62%
2001-12-31ยฃ0.35 B-10.19%
2000-12-31ยฃ0.39 B842.12%
1999-12-31ยฃ41.4 M-38.09%
1998-12-31ยฃ66.87 M97.58%
1997-12-31ยฃ33.84 M662.58%
1996-12-31ยฃ4.43 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
ยฃ7.08 B 222.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.50 B-76.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ7.44 B 238.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ11.24 B 411.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
ยฃ0.28 B-87.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
ยฃ0.18 B-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ7.32 B 232.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
ยฃ58.09 M-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
ยฃ44.29 M-97.99%๐Ÿ‡บ๐Ÿ‡ธ USA